IBX Share Price History
13 Nov, 2019
MELBOURNE, Australia, Nov. 12, 2019 /PRNewswire/ -- Imagion Biosystems Limited (IBX.AX), a company dedicated to improving healthcare through the earlier detection of cancer, has been issued patent #320872 from the Government of India Patent Office for the Company's core intellectual property related to detection, measurement and imaging using targeted magnetic nanoparticles. The newly issued patent adds India to the Company's existing global market coverage which includes Australia, Canada, China, Israel, Japan, Russia, and the U.S. The term of the India patent extends to 2030. The number of people receiving a diagnosis of cancer in India is expected to increase from 1.15 million in 2018 to 1.41 million by 2026, according to the International Agency for Research on Cancer.
30 Oct, 2019
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
16 Oct, 2019
MELBOURNE, Australia, Oct. 16, 2019 /PRNewswire/ -- Imagion Biosystems Limited (IBX.AX) (the Company), a company dedicated to improving healthcare through the earlier detection of cancer, today announces appointments to its newly established Scientific Advisory Board. Chaired by Dr John Hazle, Chair of the Department of Imaging Physics at the MD Anderson Cancer Center and previously a non-executive Director of IBX until June 2019, the Scientific Advisory Board brings together a group of highly qualified experts in disciplines ranging from oncology, medical imaging, nanotechnology and clinical trial design.
24 Sep, 2019
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
05 Aug, 2019
If you're interested in Imagion Biosystems Limited (ASX:IBX), then you might want to consider its beta (a measure of...